• Executive Summary o Market Overview • Market Landscape o Market ecosystem o Market characteristics o Value chain analysis • Market Sizing o Market definition o Market segment analysis o Market size 2019 o Market outlook: Forecast for 2019 - 2024 • Five Forces Analysis o Five forces summary o Bargaining power of buyers o Bargaining power of suppliers o Threat of new entrants o Threat of substitutes o Threat of rivalry o Market condition • Market Segmentation by Product o Market segments o Comparison by Product o Consumables - Market size and forecast 2019-2024 o Systems - Market size and forecast 2019-2024 o Market opportunity by Product • Market Segmentation by End-user o Diagnostic laboratories o Hospitals and clinics o Physicians’ office laboratories • Customer landscape • Geographic Landscape o Geographic segmentation o Geographic comparison o North America - Market size and forecast 2019-2024 o Europe - Market size and forecast 2019-2024 o Asia - Market size and forecast 2019-2024 o ROW - Market size and forecast 2019-2024 o Key leading countries o Market opportunity by geography o Market drivers o Market challenges o Market trends • Vendor Landscape o Competitive scenario o Vendor landscape o Landscape disruption • Vendor Analysis o Vendors covered o Market positioning of vendors o Abbott Laboratories o Astra Biotech GmbH o bioMérieux SA o Danaher Corp. o Hitachi Chemical Co. Ltd. o Lincoln Diagnostics Inc. o Omega Diagnostics Group Plc o PerkinElmer Inc. o Siemens Healthineers AG o Thermo Fisher Scientific Inc. • Appendix o Scope of the report o Currency conversion rates for US$ o Research methodology o List of abbreviations Exhibit • 1: Key Finding 1 • 2: Key Finding 2 • 3: Key Finding 3 • 4: Key Finding 5 • 5: Key Finding 6 • 6: Key Finding 7 • 7: Key Finding 8 • 8: Key Finding 9 • 9: Parent market • 10: Market characteristics • 11: Offerings of vendors included in the market definition • 12: Market segments • 13: Global - Market size and forecast 2019 - 2024 ($ million) • 14: Global market: Year-over-year growth 2019 - 2024 (%) • 15: Five forces analysis 2019 & 2024 • 16: Bargaining power of buyers • 17: Bargaining power of suppliers • 18: Threat of new entrants • 19: Threat of substitutes • 20: Threat of rivalry • 21: Market condition - Five forces 2019 • 22: Product - Market share 2019-2024 (%) • 23: Comparison by Product • 24: Consumables - Market size and forecast 2019-2024 ($ million) • 25: Consumables - Year-over-year growth 2019-2024 (%) • 26: Systems - Market size and forecast 2019-2024 ($ million) • 27: Systems - Year-over-year growth 2019-2024 (%) • 28: Market opportunity by Product • 29: End user - Market share 2019-2024 (%) • 30: Comparison by End user • 31: Diagnostic laboratories - Market size and forecast 2019-2024 ($ million) • 32: Diagnostic laboratories - Year-over-year growth 2019-2024 (%) • 33: Hospitals and clinics - Market size and forecast 2019-2024 ($ million) • 34: Hospitals and clinics - Year-over-year growth 2019-2024 (%) • 35: Physician office laboratories - Market size and forecast 2019-2024 ($ million) • 36: Physician office laboratories - Year-over-year growth 2019-2024 (%) • 37: Market opportunity by End user • 38: Customer landscape • 39: Market share by geography 2019-2024 (%) • 40: Geographic comparison • 41: North America - Market size and forecast 2019-2024 ($ million) • 42: North America - Year-over-year growth 2019-2024 (%) • 43: Europe - Market size and forecast 2019-2024 ($ million) • 44: Europe - Year-over-year growth 2019-2024 (%) • 45: Asia - Market size and forecast 2019-2024 ($ million) • 46: Asia - Year-over-year growth 2019-2024 (%) • 47: ROW - Market size and forecast 2019-2024 ($ million) • 48: ROW - Year-over-year growth 2019-2024 (%) • 49: Key leading countries • 50: Market opportunity by geography ($ million) • 51: Impact of drivers and challenges • 52: Vendor landscape • 53: Landscape disruption • 54: Industry risks • 55: Vendors covered • 56: Market positioning of vendors • 57: Abbott Laboratories - Overview • 58: Abbott Laboratories - Business segments • 59: Abbott Laboratories - Key offerings • 60: Abbott Laboratories - Key customers • 61: Abbott Laboratories - Segment focus • 62: Astra Biotech GmbH - Overview • 63: Astra Biotech GmbH - Product and service • 64: Astra Biotech GmbH - Key offerings • 65: Astra Biotech GmbH - Key customers • 66: Astra Biotech GmbH - Segment focus • 67: bioMérieux SA - Overview • 68: bioMérieux SA - Business segments • 69: bioMérieux SA - Key offerings • 70: bioMérieux SA - Key customers • 71: bioMérieux SA - Segment focus • 72: Danaher Corp. - Overview • 73: Danaher Corp. - Business segments • 74: Danaher Corp. - Key offerings • 75: Danaher Corp. - Key customers • 76: Danaher Corp. - Segment focus • 77: Hitachi Chemical Co. Ltd. - Overview • 78: Hitachi Chemical Co. Ltd. - Business segments • 79: Hitachi Chemical Co. Ltd. - Key offerings • 80: Hitachi Chemical Co. Ltd. - Key customers • 81: Hitachi Chemical Co. Ltd. - Segment focus • 82: Lincoln Diagnostics Inc. - Overview • 83: Lincoln Diagnostics Inc. - Product and service • 84: Lincoln Diagnostics Inc. - Key offerings • 85: Lincoln Diagnostics Inc. - Key customers • 86: Lincoln Diagnostics Inc. - Segment focus • 87: Omega Diagnostics Group Plc - Overview • 88: Omega Diagnostics Group Plc - Business segments • 89: Omega Diagnostics Group Plc - Key offerings • 90: Omega Diagnostics Group Plc - Key customers • 91: Omega Diagnostics Group Plc - Segment focus • 92: PerkinElmer Inc. - Overview • 93: PerkinElmer Inc. - Business segments • 94: PerkinElmer Inc. - Key offerings • 95: PerkinElmer Inc. - Key customers • 96: PerkinElmer Inc. - Segment focus • 97: R-Biopharm AG - Overview • 98: R-Biopharm AG - Product and service • 99: R-Biopharm AG - Key offerings • 100: R-Biopharm AG - Key customers • 101: R-Biopharm AG - Segment focus • 102: Siemens Healthineers AG - Overview • 103: Siemens Healthineers AG - Business segments • 104: Siemens Healthineers AG - Key offerings • 105: Siemens Healthineers AG - Key customers • 106: Siemens Healthineers AG - Segment focus • 107: Thermo Fisher Scientific Inc. - Overview • 108: Thermo Fisher Scientific Inc. - Business segments • 109: Thermo Fisher Scientific Inc. - Key offerings • 110: Thermo Fisher Scientific Inc. - Key customers • 111: Thermo Fisher Scientific Inc. - Segment focus • 112: Currency conversion rates for US$ • 113: Research Methodology • 114: Validation techniques employed for market sizing • 115: Information sources • 116: List of abbreviations

Abbott Laboratories, Astra Biotech GmbH, bioMérieux SA, Danaher Corp., Hitachi Chemical Co. Ltd., Lincoln Diagnostics Inc., Omega Diagnostics Group Plc, PerkinElmer Inc., R-Biopharm AG, Siemens Healthineers AG, and Thermo Fisher Scientific Inc.